Eurazeo Financial Statements From 2010 to 2025
| EUZOF Stock | USD 61.26 1.24 2.07% |
Check Eurazeo SE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eurazeo SE's main balance sheet or income statement drivers, such as , as well as many indicators such as . Eurazeo financial statements analysis is a perfect complement when working with Eurazeo SE Valuation or Volatility modules.
Eurazeo |
Eurazeo SE Company Operating Margin Analysis
Eurazeo SE's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Eurazeo SE Operating Margin | 0.27 % |
Most of Eurazeo SE's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eurazeo SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Eurazeo SE has an Operating Margin of 0.2671%. This is 98.55% lower than that of the Financial Services sector and 98.97% lower than that of the Asset Management industry. The operating margin for all United States stocks is 104.85% lower than that of the firm.
Eurazeo SE Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Eurazeo SE's current stock value. Our valuation model uses many indicators to compare Eurazeo SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eurazeo SE competition to find correlations between indicators driving Eurazeo SE's intrinsic value. More Info.Eurazeo SE is rated # 3 in return on equity category among its peers. It also is rated # 3 in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Eurazeo SE is roughly 2.64 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eurazeo SE's earnings, one of the primary drivers of an investment's value.About Eurazeo SE Financial Statements
Eurazeo SE stakeholders use historical fundamental indicators, such as Eurazeo SE's revenue or net income, to determine how well the company is positioned to perform in the future. Although Eurazeo SE investors may analyze each financial statement separately, they are all interrelated. For example, changes in Eurazeo SE's assets and liabilities are reflected in the revenues and expenses on Eurazeo SE's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Eurazeo SE. Please read more on our technical analysis and fundamental analysis pages.
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buyins of a private company, and investments in mid-market and listed public companies. . Eurazeo SE was founded in 1969 and is based in Paris, France with additional offices in North America, Asia, Europe and South America. Eurazeo Paris is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Eurazeo Pink Sheet
Eurazeo SE financial ratios help investors to determine whether Eurazeo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurazeo with respect to the benefits of owning Eurazeo SE security.